These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 30076230

  • 1. Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death.
    Richards KL, Milligan CJ, Richardson RJ, Jancovski N, Grunnet M, Jacobson LH, Undheim EAB, Mobli M, Chow CY, Herzig V, Csoti A, Panyi G, Reid CA, King GF, Petrou S.
    Proc Natl Acad Sci U S A; 2018 Aug 21; 115(34):E8077-E8085. PubMed ID: 30076230
    [Abstract] [Full Text] [Related]

  • 2. Dravet Syndrome: A Developmental and Epileptic Encephalopathy.
    Lopez-Santiago L, Isom LL.
    Epilepsy Curr; 2019 Jan 21; 19(1):51-53. PubMed ID: 30838929
    [Abstract] [Full Text] [Related]

  • 3. A selective NaV1.1 activator with potential for treatment of Dravet syndrome epilepsy.
    Chow CY, Chin YKY, Ma L, Undheim EAB, Herzig V, King GF.
    Biochem Pharmacol; 2020 Nov 21; 181():113991. PubMed ID: 32335140
    [Abstract] [Full Text] [Related]

  • 4. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
    Favero M, Sotuyo NP, Lopez E, Kearney JA, Goldberg EM.
    J Neurosci; 2018 Sep 05; 38(36):7912-7927. PubMed ID: 30104343
    [Abstract] [Full Text] [Related]

  • 5. Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome.
    Rubinstein M, Westenbroek RE, Yu FH, Jones CJ, Scheuer T, Catterall WA.
    Neurobiol Dis; 2015 Jan 05; 73():106-17. PubMed ID: 25281316
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome.
    Cheah CS, Yu FH, Westenbroek RE, Kalume FK, Oakley JC, Potter GB, Rubenstein JL, Catterall WA.
    Proc Natl Acad Sci U S A; 2012 Sep 04; 109(36):14646-51. PubMed ID: 22908258
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome.
    Valassina N, Brusco S, Salamone A, Serra L, Luoni M, Giannelli S, Bido S, Massimino L, Ungaro F, Mazzara PG, D'Adamo P, Lignani G, Broccoli V, Colasante G.
    Nat Commun; 2022 Jan 10; 13(1):161. PubMed ID: 35013317
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chronic partial TrkB activation reduces seizures and mortality in a mouse model of Dravet syndrome.
    Gu F, Parada I, Yang T, Longo FM, Prince DA.
    Proc Natl Acad Sci U S A; 2022 Feb 15; 119(7):. PubMed ID: 35165147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.